Chesley Taft & Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
15,235
+79
+0.5% +$9.12K 0.07% 173
2026
Q1
$1.81M Buy
15,156
+41
+0.3% +$5.38K 0.08% 166
2025
Q4
$2.06M Buy
15,115
+309
+2% +$44.4K 0.08% 161
2025
Q3
$2.18M Buy
14,806
+160
+1% +$22.2K 0.09% 148
2025
Q2
$1.89M Sell
14,646
-875
-6% -$106K 0.08% 155
2025
Q1
$1.85M Sell
15,521
-75
-0.5% -$9.29K 0.09% 149
2024
Q4
$1.81M Sell
15,596
-25
-0.2% -$3.16K 0.08% 151
2024
Q3
$2.11M Buy
15,621
+725
+5% +$97K 0.1% 137
2024
Q2
$2.02M Sell
14,896
-235
-2% -$32K 0.1% 134
2024
Q1
$1.96M Sell
15,131
-144
-0.9% -$17.4K 0.1% 137
2023
Q4
$1.75M Buy
15,275
+111
+0.7% +$11.1K 0.1% 142
2023
Q3
$1.38M Sell
15,164
-30
-0.2% -$3.09K 0.09% 148
2023
Q2
$1.71M Buy
15,194
+6,257
+70% +$662K 0.1% 139
2023
Q1
$936K Buy
8,937
+1,808
+25% +$189K 0.06% 178
2022
Q4
$788K Sell
7,129
-40
-0.6% -$4.19K 0.05% 185
2022
Q3
$626K Buy
7,169
+200
+3% +$18.2K 0.05% 199
2022
Q2
$545K Buy
6,969
+700
+11% +$57.8K 0.04% 213
2022
Q1
$532K Buy
6,269
+115
+2% +$11K 0.03% 229
2021
Q4
$738K Buy
6,154
+535
+10% +$66.4K 0.04% 206
2021
Q3
$695K Buy
5,619
+250
+5% +$32.2K 0.04% 203
2021
Q2
$644K Buy
5,369
+35
+0.7% +$4K 0.04% 210
2021
Q1
$568K Buy
5,334
+35
+0.7% +$3.55K 0.03% 215
2020
Q4
$539K Sell
5,299
-100
-2% -$9.4K 0.03% 210
2020
Q3
$454K Sell
5,399
-145
-3% -$11.3K 0.03% 203
2020
Q2
$360K Sell
5,544
-650
-10% -$42.9K 0.03% 216
2020
Q1
$403K Buy
+6,194
New +$488K 0.04% 197

Other funds holding XYL

Chesley Taft & Associates's XYL Position: Q2 2026 in Review

Chesley Taft & Associates increased its Xylem (XYL) stake by 0.52% in Q2 2026, buying an estimated $9.12K and bringing the position to 15,235 shares worth $1.8M. The position accounts for 0.07% of the portfolio, ranked #173.

Chesley Taft & Associates first reported a position in XYL in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.18M in Q3 2025. 146 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Chesley Taft & Associates held 15,235 shares of Xylem worth $1.8M as of Q2 2026.
  • Chesley Taft & Associates bought 79 Xylem shares in Q2 2026, an estimated $9.12K.
  • Xylem made up 0.07% of Chesley Taft & Associates's portfolio in Q2 2026, its #173 holding.
  • Chesley Taft & Associates first reported a position in Xylem in Q1 2020 and has held it in 26 quarters since.
  • Chesley Taft & Associates's Xylem position peaked at $2.18M in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.